Hill, Mitch C. 4
4 · Inari Medical, Inc. · Filed Jul 16, 2024
Insider Transaction Report
Form 4
Hill, Mitch C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-07-12$54.31/sh−1,965$106,719→ 179,227 total - Exercise/Conversion
Common Stock
2024-07-12$0.46/sh+5,000$2,285→ 184,227 total - Sale
Common Stock
2024-07-12$53.72/sh−3,035$163,040→ 181,192 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-07-12−5,000→ 66,477 totalExercise: $0.46Exp: 2029-04-23→ Common Stock (5,000 underlying)
Holdings
- 1,600(indirect: By Spouse)
Common Stock
Footnotes (4)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 9, 2023.
- [F2]This transaction was executed in multiple trades at prices ranging from $53.16 to $54.15. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F3]This transaction was executed in multiple trades at prices ranging from $54.16 to $54.52. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]Options vested with respect to 25% of the shares on April 30, 2020 and vested with respect to the remaining shares in 36 equal monthly installments thereafter.